Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Jazz Pharma Plc
(NQ:
JAZZ
)
135.14
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 17, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
135.14
Bid (Size)
126.00 (1)
Ask (Size)
153.60 (1)
Prev. Close
135.14
Today's Range
135.14 - 135.14
52wk Range
125.36 - 169.98
Shares Outstanding
62,311,104
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Medical Marijuana Milestone In The UK: Celadon Pharmaceuticals Becomes First Company With License To Sell In Britain
March 14, 2023
Celadon Pharmaceuticals has become the first UK-based medical cannabis manufacturer to be granted a Home Office license to sell its products in the UK.
Via
Benzinga
Silicon Valley Bank Failure Is Just The Tip Of Financial Iceberg, Could Affect Unexpected Industries
March 14, 2023
Last week the US economy got clobbered by the biggest banking collapse since 2008 when the parent of Silicon Valley Bank, SVB Financial Group (NASDAQ: SIVB) failed to raise enough capital to continue.
Via
Benzinga
Performance
YTD
-13.57%
-13.57%
1 Month
-8.52%
-8.52%
3 Month
-13.58%
-13.58%
6 Month
-8.73%
-8.73%
1 Year
-15.48%
-15.48%
More News
Read More
Zymeworks Offers Hope for More than Just Long-Term Investors
March 09, 2023
Via
MarketBeat
With Access To $20 Million In Financing, 1606 Corp Is Eyeing CBD Business Acquisitions As It Embarks On An Aggressive Growth Path
March 08, 2023
Via
Benzinga
The Latest Analyst Ratings for Jazz Pharmaceuticals
March 06, 2023
Via
Benzinga
Earnings Scheduled For March 1, 2023
March 01, 2023
Via
Benzinga
Earnings Preview For Jazz Pharmaceuticals
February 28, 2023
Via
Benzinga
Will Investors Notice Exciting Sign On Jazz Pharmaceuticals's Chart?
January 06, 2023
Via
Benzinga
2 Cannabis Stocks to Buy for the Long Haul
December 31, 2022
Via
The Motley Fool
Pharma Mafia Wants To Conquer Cannabis: Can You Patent A Plant? Jazz Is Trying
March 07, 2023
Via
Benzinga
Why Cannabis Is Recession-Resistant & Turning Challenges Into Opportunities, Industry Expert Explains
March 02, 2023
Via
Benzinga
Jazz Q4 2022 Revenue Grows 8% To $972M, Provides Outlook
March 02, 2023
Via
Benzinga
Cannabis-Based Medicine As A Potential Treatment For Psychosis, An Oxford University Study Says
February 17, 2023
Via
Benzinga
Teva Plots Its Knockoff Of Axsome's New Depression Drug, Sending The Biotech Sprawling
February 13, 2023
Via
Investor's Business Daily
GlycoMimetics Audio Discussion And Analysis With Dan Cohen And Scott Matusow
February 13, 2023
Via
Talk Markets
2 Cannabis Stocks That Could Make You Richer
February 09, 2023
Via
The Motley Fool
CBD-Based Life-Changing Drug For Tuberous Sclerosis Patients, Epidiolex, Now Available Via England's NHS
February 02, 2023
Via
Benzinga
3 Cannabis Stocks With Double-Digit Percentage Revenue Growth
January 30, 2023
Via
The Motley Fool
The Ultimate Growth Stocks to Buy With $300 Right Now
January 29, 2023
Via
The Motley Fool
2 Promising New Growth Stocks to Watch in 2023
January 23, 2023
Via
The Motley Fool
Jazz Pharma, Zymeworks Highlight 84% Overall Survival At 18 Months From Zanidatamab In Esophageal Cancer
January 19, 2023
Via
Benzinga
2 Stocks That Beat the Market in 2022 and That Analysts Think Can Go Higher
January 11, 2023
Via
The Motley Fool
These Stocks Jumped 100% and 30% Last Year. Here's Why They're Still a Buy.
January 07, 2023
Via
The Motley Fool
Jazz Pharmaceuticals Files Patent Infringement Against Generic Drugmakers In New Jersey's District Court
January 05, 2023
Via
Benzinga
2 Growth Stocks to Buy Heading Into 2023
December 30, 2022
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.